Compounds > cyclopentane
Page last updated: 2024-08-21

cyclopentane and Diabetic Angiopathies

cyclopentane has been researched along with Diabetic Angiopathies in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dechavanne, M; Desnoyers, P; Stoltz, JF; Vainer, H; Verry, M1
Riveline, B1
Leclercq-Meyer, V; Malaisse, WJ1
Masbernard, A; Portal, A1
Simonin, R1
Duhault, J; Lebon, F1

Trials

1 trial(s) available for cyclopentane and Diabetic Angiopathies

ArticleYear
[Long term study of a new antidiabetic agent in 1183 cases].
    Semaine des hopitaux. Therapeutique, 1974, Volume: 50, Issue:2

    Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Drug Evaluation; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Sulfonylurea Compounds

1974

Other Studies

5 other study(ies) available for cyclopentane and Diabetic Angiopathies

ArticleYear
[Effect of gliclazide on platelet behavior].
    La Nouvelle presse medicale, 1974, Oct-05, Volume: 3, Issue:33

    Topics: Adenylyl Cyclases; Blood Glucose; Blood Platelets; Carbon Radioisotopes; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Humans; Hypoglycemic Agents; Platelet Adhesiveness; Pyrroles; Sulfonylurea Compounds; Tritium; Ultracentrifugation

1974
Insulinotropic action of a new sulfonylurea: gliclazide.
    Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research, 1972, Volume: 17, Issue:3

    Topics: Animals; Cyclopentanes; Diabetic Angiopathies; Dogs; Drug Interactions; Fatty Acids, Nonesterified; Glucose; Glyburide; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Pancreas; Pyrroles; Rats; Sulfonylurea Compounds

1972
[The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Therapeutique (La Semaine des hopitaux), 1972, Volume: 48, Issue:9

    Topics: Aged; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Male; Microcirculation; Middle Aged; Pyrroles; Sex Factors; Sulfonylurea Compounds; Time Factors

1972
[Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Marseille medical, 1972, Volume: 109, Issue:10

    Topics: Adult; Aged; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Sulfonylurea Compounds

1972
The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
    Arzneimittel-Forschung, 1972, Volume: 22, Issue:10

    Topics: Animals; Blood Coagulation Tests; Capillaries; Capillary Permeability; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypoglycemic Agents; Male; Mesentery; Pyrroles; Rats; Skin; Sulfonylurea Compounds; Thrombosis

1972